Astec Lifesciences
Astec Lifesciences Share Price Chart
Astec Lifesciences last traded at ₹732.10 (2026-10-13). Over the past month the stock moved +1.7%, three months the stock moved -1.6%, year the stock moved -11.8%. Its closing range over 52 weeks is ₹541.35 – ₹841.60, with the latest close 13.0% below the high.
Closing prices up to 2026-10-13.
About Astec Lifesciences
The Company is into manufacturing of agrochemical active ingredients (technical), bulk and formulations, intermediate products and it sells its products in India as well as exports them to approximately 24 countries. Astec also has undertaken a number of custom synthesis projects, for its clients in Europe, Japan and the US. It is present only in business to business sale (B2B).[1] [2] [3]
Product Portfolio The company offers a range of products and intermediates, including fungicides, insecticides, herbicides, and various chemical compounds, serving global customers and including triazole fungicides, heterocyclic herbicides, sulfonylurea herbicides, synthetic pyrethroids, fluorinated compounds, halides, intermediates, ketones, ethers, alcohols, and many others. [1]
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Astec Lifesciences reported sales of ₹84.00 crore (-7.7%) and net profit of ₹-19.00 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 84.00 | -1.00 | -0.80 | -19.00 | -8.40 |
| Mar 2026 | 159.00 | 9.00 | 6.00 | -8.00 | -3.48 |
| Dec 2025 | 125.00 | 4.00 | 3.20 | -16.00 | -7.05 |
| Sep 2025 | 74.00 | -7.00 | -9.00 | -24.00 | -10.96 |
| Jun 2025 | 91.00 | -11.00 | -12.00 | -33.00 | -14.75 |
| Mar 2025 | 120.00 | 6.00 | 4.60 | -16.00 | -7.18 |
| Dec 2024 | 94.00 | -6.00 | -6.00 | -40.00 | -18.03 |
| Sep 2024 | 99.00 | -20.00 | -20.00 | -39.00 | -17.21 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -10.8% | +84.3% | -22.1% | +31.9% | -25.3% | +33.0% | +32.5% | -7.7% |
| Operating profit growth | – | – | -53.8% | – | – | – | +50.0% | – |
| Net profit growth | – | – | – | – | – | – | – | – |
| EPS growth | – | – | – | – | – | – | – | – |
| OPM % | -20.0% | -6.0% | 4.6% | -12.0% | -9.0% | 3.2% | 6.0% | -0.8% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Astec Lifesciences reported sales of ₹448.00 crore (+17.6%) and net profit of ₹-81.00 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 448.00 | -5.00 | -1.00 | -81.00 | -36.32 |
| Mar 2025 | 381.00 | -66.00 | -17.00 | -135.00 | -60.16 |
| Mar 2024 | 458.00 | -6.00 | -1.00 | -47.00 | -20.95 |
| Mar 2023 | 628.00 | 77.00 | 12.00 | 26.00 | 11.41 |
| Mar 2022 | 677.00 | 154.00 | 23.00 | 90.00 | 40.12 |
| Mar 2021 | 555.00 | 112.00 | 20.00 | 65.00 | 29.04 |
| Mar 2020 | 523.00 | 85.00 | 16.00 | 48.00 | 21.21 |
| Mar 2019 | 431.00 | 76.00 | 18.00 | 36.00 | 16.03 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +17.1% | +21.3% | +6.1% | +22.0% | -7.2% | -27.1% | -16.8% | +17.6% |
| Operating profit growth | +10.1% | +11.8% | +31.8% | +37.5% | -50.0% | -107.8% | – | – |
| Net profit growth | +2.9% | +33.3% | +35.4% | +38.5% | -71.1% | -280.8% | – | – |
| EPS growth | +2.4% | +32.3% | +36.9% | +38.2% | -71.6% | -283.6% | – | – |
| OPM % | 18.0% | 16.0% | 20.0% | 23.0% | 12.0% | -1.0% | -17.0% | -1.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Astec Lifesciences.
Get Free AI Stock Analysis FREE →Latest News
-
Astec Lifesciences share price skyrockets 17% despite weak sentiments on D-Street. Do you own?
-
Astec Lifesciences reports consolidated net loss of Rs 18.72 crore in the June 2026 quarter - Business Standard
-
Astec Lifesciences Ltd Shows Mildly Bullish Momentum Amid Mixed Technical Signals
-
Astec Lifesciences Ltd Surges 8.17% to Day's High of Rs 794.9 — Outperforms Sector by 7.42 Percentage Points
-
Astec LifeSciences Grants 1,142 Stock Options Under ESOP 2012 to Eligible Employee - scanx.trade
-
Astec Life Consolidated March 2026 Net Sales at Rs 158.62 crore, up 32.71% Y-o-Y - Moneycontrol.com
-
Astec Life Consolidated March 2026 Net Sales at Rs 158.62 crore, up 32.71% Y-o-Y - Moneycontrol.com
-
Astec Life Consolidated March 2026 Net Sales at Rs 158.62 crore, up 32.71% Y-o-Y - Moneycontrol.com
-
Astec Life Consolidated March 2026 Net Sales at Rs 158.62 crore, up 32.71% Y-o-Y - Moneycontrol.com
Frequently Asked Questions
What is Astec Lifesciences's current stock price?
Astec Lifesciences shares were last quoted at ₹732.10 (+0.4% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Astec Lifesciences?
Astec Lifesciences has a price-to-earnings (P/E) ratio of -24.61 and a price-to-book (P/B) ratio of 4.41. The industry P/E is 34.96.
What is the 52-week high and low of Astec Lifesciences?
The 52-week high of Astec Lifesciences is ₹936.00 and the 52-week low is ₹512.35.
What is the market cap of Astec Lifesciences?
The market capitalisation of Astec Lifesciences is about ₹1,641.58 crore.
How did Astec Lifesciences perform in its latest quarterly results?
In the latest quarter (Jun 2026), Astec Lifesciences reported sales of ₹84.00 crore (-7.7%) and net profit of ₹-19.00 crore, compared with the same quarter last year.
Is Astec Lifesciences a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Astec Lifesciences has a 3-year ROE of -26.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Astec Lifesciences?
Promoters hold about 71.96% of Astec Lifesciences.
Which sector does Astec Lifesciences belong to?
Astec Lifesciences belongs to the Pesticides & Agrochemicals sector.
Other Pesticides & Agrochemicals stocks
- PI Industries
- SUMITOMO CHEMICAL INDIA LIMITE
- Bayer CropScience
- Fine Organics Industries
- BASF India
- Sharda Cropchem
- UPL PP
- Dhanuka Agritech
All Pesticides & Agrochemicals stocks · Browse all stocks A–Z